XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Employees
Common Stock
Executive Officer [Member]
Common Stock
Consultants
Common Stock
Director
Common Stock
Paid-In Capital [Member]
Employees
Paid-In Capital [Member]
Executive Officer [Member]
Paid-In Capital [Member]
Consultants
Paid-In Capital [Member]
Retained Earnings (Accumulated Deficit) [Member]
Noncontrolling Interest [Member]
Employees
Executive Officer [Member]
Consultants
Total
Balances at Dec. 31, 2020         $ 19       $ 102,324 $ (16,595) $ 507       $ 86,255
Balances (in shares) at Dec. 31, 2020         19,260,862                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 169           169
Shares issued on exercise of stock options, net (in shares)         1,667                    
Net income (loss)                   (2,547) (81)       (2,628)
Balances at Mar. 31, 2021         $ 19       102,493 (19,142) 426       83,796
Balances (in shares) at Mar. 31, 2021         19,262,529                    
Balances at Dec. 31, 2020         $ 19       102,324 (16,595) 507       86,255
Balances (in shares) at Dec. 31, 2020         19,260,862                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss)                             (5,801)
Balances at Sep. 30, 2021         $ 20       102,936 (21,836) 947       82,067
Balances (in shares) at Sep. 30, 2021         19,541,921                    
Balances at Mar. 31, 2021         $ 19       102,493 (19,142) 426       83,796
Balances (in shares) at Mar. 31, 2021         19,262,529                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 52           52
Shares issued to executive related to stock grants for bonus payments   $ 1         $ 282           $ 283    
Shares issued to executive related to stock grants for bonus payments (in shares)   181,179                          
Shares issued to consultant in connection with stock grant               $ 25           $ 25  
Shares issued to consultant in connection with stock grant (in shares)     14,045 50,000                      
Shares issued on exercise of stock options, net (in shares)         23,102                    
Net income (loss)                   (1,558) (256)       (1,814)
Balances at Jun. 30, 2021         $ 20       102,852 (20,700) 170       82,342
Balances (in shares) at Jun. 30, 2021         19,530,855                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 59           59
Shares issued to consultant in connection with stock grant               25           25  
Shares issued to consultant in connection with stock grant (in shares)     9,399                        
Shares issued on exercise of stock options, net (in shares)         1,667                    
Additional investment in Longaberger Licensing, LLC by non-controlling interest holder                     1,000       1,000
Net income (loss)                   (1,136) (223)       (1,359)
Balances at Sep. 30, 2021         $ 20       102,936 (21,836) 947       82,067
Balances (in shares) at Sep. 30, 2021         19,541,921                    
Balances at Dec. 31, 2021         $ 20       103,039 (28,779) 662       74,942
Balances (in shares) at Dec. 31, 2021         19,571,119                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 30           30
Net income (loss)                   (3,487) (252)       (3,739)
Balances at Mar. 31, 2022         $ 20       103,069 (32,266) 410       71,233
Balances (in shares) at Mar. 31, 2022         19,571,119                    
Balances at Dec. 31, 2021         $ 20       103,039 (28,779) 662       74,942
Balances (in shares) at Dec. 31, 2021         19,571,119                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss)                             1,020
Balances at Sep. 30, 2022         $ 20       103,541 (26,818) (279)       76,464
Balances (in shares) at Sep. 30, 2022         19,624,860                    
Balances at Mar. 31, 2022         $ 20       103,069 (32,266) 410       71,233
Balances (in shares) at Mar. 31, 2022         19,571,119                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 402           402
Shares issued to executive related to stock grants for bonus payments             281           281    
Shares issued to executive related to stock grants for bonus payments (in shares)   178,727                          
Shares issued in connection with sale transaction (see Note 2 and Note 8)               97           97  
Shares issued in connection with sale transaction (see Note 2 and Note 8) (in shares)     65,275                        
Shares issued to consultant in connection with stock grant           $ 50   $ 33       $ 50   $ 33  
Shares issued to consultant in connection with stock grant (in shares) 33,557   20,064 50,000                      
Shares repurchased in exchange for withholding taxes           $ (357) $ (85)         $ (357) $ (85)    
Shares repurchased in exchange for withholding taxes (in shares) (240,000) (53,882)                          
Net income (loss)                   9,490 (301)       9,189
Balances at Jun. 30, 2022         $ 20       103,490 (22,776) 109       80,843
Balances (in shares) at Jun. 30, 2022         19,624,860                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 51           51
Net income (loss)                   (4,042) (388)       (4,430)
Balances at Sep. 30, 2022         $ 20       $ 103,541 $ (26,818) $ (279)       $ 76,464
Balances (in shares) at Sep. 30, 2022         19,624,860